Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: A preliminary report

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 4, 2008, Pages 348-351

  Ilzecka J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Amyotrophic lateral sclerosis; Angiogenesis; Endoglin; Neurodegeneration; Serum

Indexed keywords

ENDOGLIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MOTONEURON; NERVE DEGENERATION; PRIORITY JOURNAL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE;

EID: 46949083065     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510701604628     Document Type: Article

References (27)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-60.
2. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-β pathways. J Biol Chem 2002;277:43799-808.
3. Bellon T, Corbi A, Lastres P, Cales C, Cebrian M, Vera S, et al. Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 1993;23:2340-5.
4. Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003;17:984-92.
5. Wong SH, Hamel L, Chevalier S, Philip A. Endoglin expression on human microvascular endothelial cells association with βglycan and formation of higher order complexes with TGF-β signalling receptors. Eur J Biochem 2000;267:5550-60.
6. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, et al. Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J 2004;23:4018-28.
7. Tesseur I, Wyss-Coray T. A role for TGF-β signaling in neurodegeneration: evidence from genetically engineered models. Curr Alzh Res 2006;3:505-13.
8. Lastres P, Letamendia A, Zhang H, Rius C, Almendro M, Raab U, et al. Endoglin modulates cellular responses to TGF-β1. J Cell Biol 1996;133:1109-21.
9. Brooks BR. El Escorial Word Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124 Suppl:96-107.
10. Gordon PH, Miller RG, Moore DH. ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:90-3.
11. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003;34:383-94.
12. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001;28:131-8.
13. Greenberg DA, Jin K. From angiogenesis to neuropathology. Nature 2005;438:954-9.
14. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kinqsman SM, et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004;429:413-7.
15. Zheng C, Nennesmo I, Fadeel B, Henter JI. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2004;56:564-7.
16. Lambrechts D, Lafuste P, Carmeliet P, Conway EM. Another angiogenic gene linked to amyotrophic lateral sclerosis. Trends Mol Med 2006;12:345-7.
17. Greenway MJ, Alexander MD, Ennis S, Traynor BJ, Corr B, Frost E, et al. A novel candidate region for ALS on chromosome 14q11.2. Neurology 2004;63:1936-8.
18. Nygren I, Larsson A, Johansson A, Askmark H. VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis. Neuroreport 2002;13:2199-201.
19. Cronin S, Greenway MJ, Ennis S, Kieran D, Green A, Prehn JH, et al. Elevated serum angiogenin levels in ALS. Neurology 2006;67:1833-6.
20. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, et al. Defective angiogenesis in mice lacking endoglin. Science 1999;284:1534-7.
21. van Laake LW, van den Driesche S, Post S, Feijen A, Jansen MA, Driessens HM, et al. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 2006;114:2288-97.
22. Dziewulska D, Rafalowska J. Role of endoglin and transforming growth factor-β in progressive white matter damage after an ischemic stroke. Neuropathology 2006;26:298-306.
23. Xu B, Wu YQ, Huey M, Arthur HM, Marchuk DA, Hashimoto T, et al. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab 2004;24:237-44.
24. Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, Karlsson S, et al. Defective paracrine signaling by TGFβ in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 2004;131:6237-47.
25. Zhu Y, Sun Y, Xie L, Jin K, Sheibani N, Greenberg DA. Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells. Stroke 2003;34:2483-8.
26. Jerkic M, Rodriquez-Barbero A, Prieto M, Toporsian M, Pericacho M, Rivas-Elena JV, et al. Reduced angiogenic responses in adult endoglin heterozygous mice. Cardiovasc Res 2006;69:845-54.
27. Tesseur I, Zou K, Esposito L, Bard F, Berber E, van Can J, et al. Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest 2006;116:3060-9.